Post-approval studies (Phase 4)WithdrawnNCT04330495
What this trial is testing
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection
Who this might be right for
COVID 19Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Instituto de Investigación Marqués de Valdecilla